Katherine Marks

2.1k total citations · 1 hit paper
15 papers, 930 citations indexed

About

Katherine Marks is a scholar working on Molecular Biology, Virology and Genetics. According to data from OpenAlex, Katherine Marks has authored 15 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Virology and 4 papers in Genetics. Recurrent topics in Katherine Marks's work include RNA modifications and cancer (4 papers), HIV Research and Treatment (4 papers) and Diabetes and associated disorders (3 papers). Katherine Marks is often cited by papers focused on RNA modifications and cancer (4 papers), HIV Research and Treatment (4 papers) and Diabetes and associated disorders (3 papers). Katherine Marks collaborates with scholars based in Australia, United States and United Kingdom. Katherine Marks's co-authors include Lana Saleh, Esta Tamanaha, Shengxi Guan, Jake Powrie, Mark Peakman, Sefina Arif, Anthony D. Kelleher, Chantelle Ahlenstiel, Kazuo Suzuki and Fang Yuan and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Diabetes.

In The Last Decade

Katherine Marks

15 papers receiving 912 citations

Hit Papers

Enzymatic methyl sequencing detects DNA methylation at si... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine Marks Australia 13 413 368 224 215 186 15 930
Isis Ricaño-Ponce Netherlands 14 178 0.4× 291 0.8× 168 0.8× 335 1.6× 67 0.4× 25 812
Eric C. Hsu Canada 9 135 0.3× 205 0.6× 70 0.3× 169 0.8× 79 0.4× 10 757
Helen L. Del Puerto Brazil 18 192 0.5× 122 0.3× 49 0.2× 145 0.7× 46 0.2× 53 751
K Hioki Japan 13 235 0.6× 119 0.3× 62 0.3× 187 0.9× 25 0.1× 29 700
Patricia Lobelle‐Rich United States 14 147 0.4× 151 0.4× 33 0.1× 194 0.9× 33 0.2× 27 468
Tamir Ellis United States 11 211 0.5× 323 0.9× 107 0.5× 55 0.3× 59 0.3× 15 575
Junzo Saegusa Japan 12 156 0.4× 120 0.3× 59 0.3× 296 1.4× 42 0.2× 39 721
Martial Lacroix Canada 15 171 0.4× 159 0.4× 23 0.1× 74 0.3× 77 0.4× 27 730
Michael B.A. Oldstone United States 11 233 0.6× 145 0.4× 53 0.2× 518 2.4× 29 0.2× 12 1.1k
Rachel R. Higgins Canada 15 259 0.6× 128 0.3× 55 0.2× 47 0.2× 38 0.2× 23 580

Countries citing papers authored by Katherine Marks

Since Specialization
Citations

This map shows the geographic impact of Katherine Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Marks more than expected).

Fields of papers citing papers by Katherine Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Marks. The network helps show where Katherine Marks may publish in the future.

Co-authorship network of co-authors of Katherine Marks

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Marks. A scholar is included among the top collaborators of Katherine Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Marks. Katherine Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Vaisvila, Romualdas, V. K. Chaithanya Ponnaluri, Zhiyi Sun, et al.. (2021). Enzymatic methyl sequencing detects DNA methylation at single-base resolution from picograms of DNA. Genome Research. 31(7). 1280–1289. 262 indexed citations breakdown →
2.
Lee, Yan‐Jiun, Nan Dai, Stephanie Müller, et al.. (2021). Pathways of thymidine hypermodification. Nucleic Acids Research. 50(6). 3001–3017. 12 indexed citations
3.
Buswell, J. A., Siu‐Hong Chan, Nan Dai, et al.. (2019). The yeast scavenger decapping enzyme DcpS and its application for in vitro RNA recapping. Scientific Reports. 9(1). 15 indexed citations
5.
Zaunders, John, Mark Danta, Michelle Bailey, et al.. (2016). CD4+ T Follicular Helper and IgA+ B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals. Frontiers in Immunology. 7. 438–438. 12 indexed citations
6.
Tamanaha, Esta, Shengxi Guan, Katherine Marks, & Lana Saleh. (2016). Distributive Processing by the Iron(II)/α-Ketoglutarate-Dependent Catalytic Domains of the TET Enzymes Is Consistent with Epigenetic Roles for Oxidized 5-Methylcytosine Bases. Journal of the American Chemical Society. 138(30). 9345–9348. 39 indexed citations
7.
Suzuki, Kazuo, Chantelle Ahlenstiel, Katherine Marks, & Anthony D. Kelleher. (2015). Promoter Targeting RNAs: Unexpected Contributors to the Control of HIV-1 Transcription. Molecular Therapy — Nucleic Acids. 4. e222–e222. 24 indexed citations
8.
Ahlenstiel, Chantelle, Kazuo Suzuki, Katherine Marks, Geoff Symonds, & Anthony D. Kelleher. (2015). Controlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional Cure. Frontiers in Immunology. 6. 474–474. 15 indexed citations
9.
Ahlenstiel, Chantelle, Katherine Marks, Stuart Turville, et al.. (2015). Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing. Molecular Therapy — Nucleic Acids. 4. e261–e261. 40 indexed citations
10.
Arif, Sefina, Pia Leete, Vy Nguyen, et al.. (2015). Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes (vol 63, pg 3835, 2014). 1 indexed citations
11.
Arif, Sefina, Pia Leete, Katherine Marks, et al.. (2014). Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes. Diabetes. 63(11). 3835–3845. 178 indexed citations
12.
Suzuki, Kazuo, Shin-ichiro Hattori, Katherine Marks, et al.. (2013). Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing. Molecular Therapy — Nucleic Acids. 2. e137–e137. 42 indexed citations
13.
Arif, Sefina, Fabrice Moore, Katherine Marks, et al.. (2011). Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death. Diabetes. 60(8). 2112–2119. 173 indexed citations
14.
Yuan, Fang, Katherine Marks, Melanie Wong, et al.. (2008). Clinical relevance of TLR2, TLR4, CD14 and FcγRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunology and Cell Biology. 86(3). 268–270. 91 indexed citations
15.
Yuan, Fang, Ingrid Boehm, Paul K.S. Chan, et al.. (2007). High Prevalence of the CD14-159CC Genotype in Patients Infected with Severe Acute Respiratory Syndrome-Associated Coronavirus. Clinical and Vaccine Immunology. 14(12). 1644–1645. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026